Overview
Key stats
Fundamentals Sep 10- Open
- $45.00
- 52-wk high
- $61.11
- High
- $45.40
- 52-wk low
- $34.15
- Low
- $44.52
- Prev close
- $45.16
- Mkt cap
- $199.56B
- P/E
- 11.1x
- Volume
- 8.83M
- Fwd P/E
- 14.2x
- Beta
- 0.34
- Div yield
- 3.98%
- P/S
- 0.6x
- P/B
- 6.0x
- Profit margin
- +35.3%
- Op margin
- +42.5%
- ROE
- +59.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 17.1% above what analysts expected.
Earnings per share
$0.82 expected
What the street expects next
EPS expected
$4.68 to $5.33
Revenue expected
9 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 35.3%
- P/E
- 11.10
- Forward P/E
- 14.20
- Market cap
- $199.6B
Valuation
- P/S0.61
- P/B6.01
- Dividend yield4.0%
Quality
- Operating margin42.5%
- ROE59.8%
- ROA18.7%
Growth
- Beta0.34
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial
NeutralSep 7Novo Nordisk's IL-6 drug flunks two more heart trials
Leans bearishSep 7Novo Nordisk says semaglutide cut obesity rates in young children in trial
BullishSep 7Novo Nordisk Foundation to build $62M quantum chip plant in Copenhagen
BullishSep 4Citi flags GLP-1 prescription slowdown at Novo Nordisk, reiterates 'sell'
BearishSep 2Novo Nordisk A/S : Deutsche Bank reiterates its Sell rating
BearishSep 2Novo Nordisk launches Wegovy weight-loss pill in Germany
Leans bullishSep 2Ozempic maker Novo Nordisk downgraded to sell following 70% stock-price dive from peak
BearishAug 27
Macro
21 macro signals shaping NVO right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results